Filing Details

Accession Number:
0001179110-17-004436
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-10 17:20:34
Reporting Period:
2017-03-08
Filing Date:
2017-03-10
Accepted Time:
2017-03-10 17:20:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551152 Abbvie Inc. ABBV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239127 A Richard Gonzalez 1 N. Waukegan Road
North Chicago IL 60064
Chairman Of The Board And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2017-03-08 18,366 $24.21 369,113 No 4 M Direct
Common Stock, $0.01 Par Value Acquisiton 2017-03-08 53,650 $29.23 422,763 No 4 M Direct
Common Stock, $0.01 Par Value Disposition 2017-03-08 72,016 $64.25 350,747 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2017-03-10 785 $0.00 349,962 No 5 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 5 G Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2017-03-08 18,366 $0.00 18,366 $24.21
Common Stock Option (right to buy) Disposition 2017-03-08 53,650 $0.00 53,650 $29.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-18 2021-02-17 No 4 M Direct
0 2015-02-17 2022-02-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 4,600 Indirect By spouse
Common Stock, $0.01 Par Value 450 Indirect By step-daughter
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities.
  2. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.